Additionally, the proportions of patients with RPL who had autoimmune diseases and aPLs in the anti-β2GPI/HLA-DR antibody-positive population were significantly higher than those in anti-β2GPI/HLA-DR antibody-negative population. The gene discussed is APOH; the disease is autoimmune disease.